About Emory University School of Medicine/Winship Cancer Institute Dept. of Hematology (2)
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at Emory University School of Medicine/Winship Cancer Institute Dept. of Hematology (2)
During the past decade, Emory University School of Medicine/Winship Cancer Institute Dept. of Hematology (2) conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 3 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Emory University School of Medicine/Winship Cancer Institute Dept. of Hematology (2)
According to Clinical.Site data, the most researched conditions in "Emory University School of Medicine/Winship Cancer Institute Dept. of Hematology (2)" are
"Classical Hodgkin's Lymphoma" (1 trials), "Cutaneous T-Cell Lymphoma" (1 trials), "Metastatic Breast Cancer" (1 trials) and "Smoldering Multiple Myeloma" (1 trials). Many other conditions were trialed in "Emory University School of Medicine/Winship Cancer Institute Dept. of Hematology (2)" in a lesser frequency.
Clinical Trials Intervention Types at Emory University School of Medicine/Winship Cancer Institute Dept. of Hematology (2)
Most popular intervention types in "Emory University School of Medicine/Winship Cancer Institute Dept. of Hematology (2)" are "Drug" (4 trials). Other intervention types were less common.
The name of intervention was led by "Panobinostat" (2 trials), "BHQ880" (1 trials), "Everolimus" (1 trials), "Paclitaxel" (1 trials) and "Trastuzumab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Emory University School of Medicine/Winship Cancer Institute Dept. of Hematology (2)
The vast majority of trials in "Emory University School of Medicine/Winship Cancer Institute Dept. of Hematology (2)" are
3 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Emory University School of Medicine/Winship Cancer Institute Dept. of Hematology (2)
Currently, there are NaN active trials in "Emory University School of Medicine/Winship Cancer Institute Dept. of Hematology (2)".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Emory University School of Medicine/Winship Cancer Institute Dept. of Hematology (2),
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Emory University School of Medicine/Winship Cancer Institute Dept. of Hematology (2), 1 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".